Karyopharm Therapeutics (KPTI) Prepaid Assets (2012 - 2026)

Karyopharm Therapeutics (KPTI) has 14 years of Prepaid Assets data on file, last reported at $9.2 million in Q4 2025.

• Quarterly Prepaid Assets fell 24.98% year-over-year to $9.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.2 million (down 24.98% YoY) and the FY2025 annual result came in at $9.2 million, down 24.98% from the prior year.
• Prepaid Assets improved to $9.2 million in Q4 2025, from $8.0 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $31.5 million in Q3 2022 to a low of $8.0 million in Q3 2025.
• A 5-year average of $14.0 million and a median of $12.8 million in 2021 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2022 — Prepaid Assets jumped 156.42% — and 2023, when it tumbled 57.63%.
• Tracing KPTI's Prepaid Assets over 5 years: stood at $14.0 million in 2021, then jumped by 41.19% to $19.8 million in 2022, then plunged by 40.4% to $11.8 million in 2023, then climbed by 3.66% to $12.2 million in 2024, then retreated by 24.98% to $9.2 million in 2025.
• The last three Prepaid Assets figures came in at $9.2 million (Q4 2025), $8.0 million (Q3 2025), and $8.2 million (Q2 2025), per Business Quant data.